Doxorubicin
ADVERTISEMENT
- Molecular formula
- C27H29N1O11
- CAS Number
- 23214-92-8
- IUPAC Name
- [(7R,8S)-7-hydroxy-5,12-dimethyl-11-(methylamino)-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate
- Molecular Weight
- 543.52g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.6009g/cm3
Identification
Interesting facts
Interesting Facts about [(7R,8S)-7-hydroxy-5,12-dimethyl-11-(methylamino)-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate
This complex compound, often referred to by its systematic name, belongs to a class of chemicals known for their unique structural arrangements and biological activities. Here are some intriguing insights:
- Structural Intricacy: The compound's tetracyclic backbone indicates a highly complex molecular architecture, which contributes to its potential activity in various biochemical pathways.
- Biological Relevance: With multiple functional groups, particularly the hydroxyl and amino substituents, it may exhibit intriguing interactions with biological macromolecules, which could be valuable in drug design.
- Potential Applications: Due to its diverse functional groups, this compound could serve as a template for the development of therapeutics aimed at a range of conditions, perhaps particularly in the realm of cancer or neurological disorders.
- Synthetic Challenges: The synthesis of such a multi-faceted structure often requires sophisticated methodologies, including multi-step reactions and careful stereochemical control to achieve the desired chirality.
- Avenue for Research: The exploration of this compound can pave the way for developing novel scaffolds in medicinal chemistry, possibly leading to new discoveries in pharmacology.
In conclusion, the compound's intricate structure and functional diversity position it as a promising candidate for further scientific exploration. As chemists continue to unveil the potential applications, this compound could play a vital role in advancing pharmaceutical research and development.